A detailed history of Cary Street Partners Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cary Street Partners Asset Management LLC holds 18,865 shares of PFE stock, worth $501,054. This represents 0.08% of its overall portfolio holdings.

Number of Shares
18,865
Previous 17,627 7.02%
Holding current value
$501,054
Previous $493,000 10.55%
% of portfolio
0.08%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$27.7 - $31.39 $34,292 - $38,860
1,238 Added 7.02%
18,865 $545,000
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $7,224 - $8,465
286 Added 1.65%
17,627 $493,000
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $25,190 - $28,927
973 Added 5.94%
17,341 $481,000
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $705 - $916
27 Added 0.17%
16,368 $471,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $125,953 - $147,226
-3,925 Reduced 19.37%
16,341 $542,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $577 - $668
16 Added 0.08%
20,266 $743,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $39 - $51
-1 Reduced -0.0%
20,250 $826,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $83,541 - $109,054
2,001 Added 10.96%
20,251 $1.04 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $210,748 - $257,270
-4,816 Reduced 20.88%
18,250 $799,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $4,653 - $5,517
100 Added 0.44%
23,066 $1.21 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $203,175 - $251,760
4,441 Added 23.97%
22,966 $1.19 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $39,250 - $50,420
-1,000 Reduced 5.12%
18,525 $797,000
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $653,892 - $737,459
19,525 New
19,525 $707,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cary Street Partners Asset Management LLC Portfolio

Follow Cary Street Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Asset Management LLC with notifications on news.